8868 Results

People

  1. Brennan
    Brennan
  2. Gonen
    Gonen
  3. Jarnagin
    Jarnagin
  4. Vickers
    Vickers
  5. D'Angelica
    D'Angelica
  6. Motzer
    Motzer
  7. Herr
    Herr
  8. Fong
    Fong
  9. Shah
    Shah
  10. DeMatteo
    DeMatteo

Groups

  1. Surgery (3176)
  2. Department of Medicine (3150)
  3. Survivorship Research (2193)
  4. Solid Tumor Oncology Division (1878)
  5. Epidemiology and Biostatistics (1827)
  6. Population Sciences Research Program (1674)
  7. Biostatistics Service (1218)
  8. Department of Pathology and Laboratory Medicine (1112)
  9. GSK Faculty (1030)
  10. Sloan Kettering Institute Faculty (960)
  1. "major clinical study"
Formats
  1. Journal Article (8582)
  2. Conference Paper (110)
  3. Research Letter (96)
  4. Review (38)
  5. Editorial (17)
  6. Correspondence (12)
  7. Meeting Abstract (5)
  8. Guidelines (4)
  9. Miscellaneous (4)
Groups
  1. Surgery (3176)
  2. Department of Medicine (3150)
  3. Survivorship Research (2193)
  4. Solid Tumor Oncology Division (1878)
  5. Epidemiology and Biostatistics (1827)
  6. Population Sciences Research Program (1674)

More Groups

People
  1. Murray Brennan (305)
  2. Mithat Gonen (262)
  3. Peter Scardino (228)
  4. William Jarnagin (207)
  5. Andrew Vickers (201)
  6. Michael D'Angelica (177)

More People

Years
  1. 2025 (285)
  2. 2024 (692)
  3. 2023 (426)
  4. 2022 (332)
  5. 2021 (212)
  6. 2020 (435)

More Years

Publications
  1. Cancer (505)
  2. Journal of Clinical Oncology (470)
  3. Annals of Surgical Oncology (363)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Gynecologic Oncology (231)
  6. Journal of Urology (227)

More Publications

Publishers
  1. Elsevier Inc. (1324)
  2. Elsevier Science, Inc. (953)
  3. Wiley Blackwell (846)
  4. Springer (760)
  5. Lippincott Williams & Wilkins (553)
  6. American Society of Clinical Oncology (526)

More Publishers

Results (8868)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effects of enzalutamide on the sexual activity of patients with biochemically recurrent prostate cancer: A post hoc analysis of patient-reported outcomes in the EMBARK study
    Journal Article

    Freedland, S. J.; Mulhall, J. P.; Gleave, M.; Giorgi, U. D.; Saad, F.; Rannikko, A.; Ivanova, J. I.; Nasr, A. F.; Reisman, A. L.; Ganguli, A.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Sustained improvement in health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone: MAIA final analysis of patient-reported outcomes
    Journal Article

    Perrot, A.; Facon, T.; Plesner, T.; Usmani, S. Z.; Kumar, S.; Bahlis, N. J.; Hulin, C.; Orlowski, R. Z.; Nahi, H.; Mollee, P.; more...
    European Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sample
    Journal Article

    Mead-Harvey, C.; Basch, E.; Rogak, L. J.; Langlais, B. T.; Thanarajasingam, G.; Ginos, B. F.; Lee, M. K.; Yee, C.; Mitchell, S. A.; Minasian, L. M.; more...
    Clinical Trials (2025)

    Fulltext@MSK | Save
  • Automated description generation of cytologic findings for lung cytological images using a pretrained vision model and dual text decoders: Preliminary study
    Journal Article

    Teramoto, A.; Michiba, A.; Kiriyama, Y.; Tsukamoto, T.; Imaizumi, K.; Fujita, H.
    Cytopathology (2025)

    Fulltext@MSK | Save
  • Oncotype DX recurrence score in node-positive patients in the post-RxPONDER era: A single-institution experience
    Journal Article

    Han, R.; Brogi, E.; Thompson, D.; El-Tamer, M.; Morrow, M.; Wen, H. Y.
    Breast Cancer Research and Treatment (2025)

    Fulltext@MSK | Save
  • Disparities in stage at presentation for disaggregated Asian American, Native Hawaiian, and Pacific Islander patients with breast cancer
    Journal Article

    Thaploo, A.; Kohli, K.; Wang, S.; Ho, F. D. V.; Feliciano, E. J. G.; Wang, K.; Ong, E. P.; Jain, B.; Kohli, M.; Chou, C.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Racial and ethnic differences in breast inflammation and its association with lymphedema risk after axillary lymph node dissection
    Journal Article

    Roberts, A.; Campbell, A. C.; Pollack, B. L.; Montagna, G.; Sevilimedu, V.; Axelrod, B.; Gomez, E. A.; Giri, D.; Morrow, M.; Mehrara, B. J.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: A pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials
    Journal Article

    Williams, H.; Fokas, E.; Diefenhardt, M.; Lee, C.; Verheij, F. S.; Omer, D. M.; Lin, S. T.; Dunne, R. F.; Marcet, J.; Cataldo, P.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: Final analysis of the phase III JAVELIN Renal 101 trial
    Journal Article

    Choueiri, T. K.; Penkov, K.; Uemura, H.; Campbell, M. T.; Pal, S.; Kollmannsberger, C.; Lee, J. L.; Venugopal, B.; van den Eertwegh, A. J. M.; Negrier, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Biomarker analyses from the phase III randomized CLEAR trial: Lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Grünwald, V.; George, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save